Phreesia PHR

Chaim Indig Director since 2016 Professional Summary: Chaim Indig is the Founder and Chief Executive Officer of Phreesia, Inc., a role held since the company's founding in 2005. Phreesia is a leading healthcare services company that helps medical organizations improve patient access and experience, while also enabling healthcare stakeholders to better connect with patients. Since its inception, Phreesia has focused on transforming the patient intake and engagement experience through technology-driven solutions. Experience and Expertise: As Chief Executive Officer, Chaim Indig has led Phreesia through significant growth, including the company's public offering and expansion across healthcare providers nationwide. His experience includes strategic planning, operational leadership, product development, and scaling technology platforms in regulated healthcare environments. He has overseen the development of solutions that improve workflow efficiency, patient satisfaction, and data-driven engagement for healthcare organizations. Career Highlights: Chaim Indig has served as Founder and Chief Executive Officer of Phreesia (NYSE: PHR) from 2005 to the present. Prior to Phreesia, he served as Manager at Monitor Group from 2001 to 2005. Key Skills: His key skills include healthcare technology and SaaS leadership, patient access and engagement solutions, public company leadership, growth strategy, healthcare revenue cycle and payments, and long-term product strategy.

Evan Roberts has served as our President, Provider Solutions since July 2025 and is a co-founder of Phreesia. In this role, Mr. Roberts oversees Phreesia's Provider business, including Customer Solutions, Customer Operations, Sales and Sales Development, bringing more than 20 years of leadership experience to the Company. Mr. Roberts previously served as Chief Operating Officer from January 2019 to June 2025, where he spearheaded the creation of the Company's contracted software development teams, led Phreesia's acquisitions and established Phreesia's India operations. Since co-founding Phreesia in January 2005, Mr. Roberts has held a series of senior leadership roles across the organization, including serving as the Company's first Chief Technology Officer and later leading Customer Solutions. Having touched every part of the business over two decades, Mr. Roberts remains deeply focused on building products and teams that make healthcare simpler for everyone. Mr. Roberts received his B.S. degree in Computer Engineering from Tufts University.

Balaji Gandhi has served as our Chief Financial Officer since March 2023. In this role, Mr. Gandhi oversees the Company's budgeting, forecasting, financial reporting, financial analysis, internal controls and investor relations, bringing more than 20 years of healthcare finance and capital markets experience to Phreesia. He previously served as our SVP, Investor Relations from February 2021 to March 2023, having joined Phreesia in July 2019 as Vice President, Investor Relations in preparation for the Company's initial public offering. Prior to Phreesia, Mr. Gandhi served as Chief Financial Officer of Madaket Health, a cloud-based healthcare software-as-a-service company, and built his career across healthcare finance, investment research and corporate strategy. Mr. Gandhi's time on both the operating side and the capital markets side of healthcare gives him a distinctive perspective on connecting Phreesia's financial strategy to its mission of creating a better healthcare experience. Mr. Gandhi received his bachelor's degree from the University of Rochester and received his Master of Health Services Administration, Health Policy Analysis from The George Washington University.

David Linetsky has served as our President, Network Solutions since July 2025. In this role, Mr. Linetsky is responsible for cultivating Phreesia's partnerships with life sciences companies, advocacy groups, government agencies and other organizations, bringing nearly two decades of experience at Phreesia and a deep background in data science and analytics to his leadership of the Company's network solutions business. Mr. Linetsky previously served as our Senior Vice President, Network Solutions from March 2019 to June 2025, during which time he built and led the Company's Life Sciences organization and founded Phreesia's data science team. Since first joining Phreesia in 2005, Mr. Linetsky has held a series of leadership roles spanning finance, analytics and data science, contributing to the Company's growth from a startup to a publicly traded healthcare technology company. With roots in academic mathematics, Mr. Linetsky combines analytical rigor with a deep understanding of the healthcare ecosystem to drive the Company's network solutions strategy. Mr. Linetsky received his B.S. degree in Mathematics from the University of Alberta and his M.Phil. degree in Mathematics and Logic from the Graduate Center of the City University of New York, where he was also a Ph.D. candidate in Mathematics and Logic.

Allison Hoffman has served as our General Counsel and Secretary since August 2020. In this role, Ms. Hoffman manages the Company's Legal, Privacy and Compliance teams, bringing more than 25 years of legal and people-management experience to Phreesia. Prior to joining Phreesia, Ms. Hoffman served as Chief Legal and Administrative Officer at Intersection Parent, Inc., a digital technology company, where she oversaw both the legal and human resources functions. Throughout her career, Ms. Hoffman has served in dual legal and administrative leadership roles at public and private companies, including Martha Stewart Living Omnimedia, Inc., where she oversaw the company's sale, and began her legal career at Skadden, Arps, Slate, Meagher & Flom LLP. Ms. Hoffman also serves as a director of Network-1 Technologies, Inc. Ms. Hoffman received a B.A. in Psychology and a B.S. in Economics from the University of Pennsylvania and a Juris Doctor from the University of Chicago Law School.

Gillian Munson Independent Director Since May 2019 Professional Summary: Gillian Munson is a seasoned public company Chief Financial Officer with more than 30 years of operating leadership. She currently serves as Chief Financial Officer of Duolingo and has previously held Chief Financial Officer roles at Vimeo, Iora Health, and XO Group, the parent company of The Knot. Across these roles, she has led finance organizations through growth, operational transformation, and public company scaling across the healthcare and technology sectors. As Chief Financial Officer of Vimeo, she led cost control, margin expansion, and balance-sheet discipline initiatives that enabled the SaaS business to stabilize and pivot to profitability and cash generation in a short period, culminating in the company being taken private at an over 90 percent premium. Audit, Reporting, and Financial Oversight Expertise: Ms. Munson brings significant audit and financial reporting expertise. As a highly experienced public company Chief Financial Officer who has also served on public company boards, she has worked extensively with and on audit committees to oversee internal controls, financial reporting processes, and disclosure practices, and she qualifies as an audit committee financial expert under Securities and Exchange Commission regulations. She has direct experience managing the financial reporting and compliance demands of companies undergoing significant operational and strategic transformation. Her background as a former investment banker and equity analyst further informs her engagement with boards on risk oversight, capital allocation, and long-term value creation. Capital Markets, M&A, and Investment Experience: Ms. Munson has extensive experience with transformative mergers and acquisitions, capital allocation, and capital markets execution. Throughout her career, she has led acquisition strategy, transaction execution, and post-merger integration efforts, applying disciplined capital deployment frameworks to support long-term shareholder value creation. Her transaction experience includes Vimeo's $1.38 billion acquisition by Bending Spoons in 2025, Iora Health's $2.1 billion acquisition by One Medical in 2021, after which she supported post-merger integration as a special advisor, and XO Group's $933 million merger with WeddingWire in 2018. She began her career in research at Hambrecht & Quist and later served as a senior equity analyst at Morgan Stanley before working in investment banking and venture capital, providing firsthand insight into how investors evaluate public company performance, valuation, and strategic positioning. This foundation directly informs her approach to investor relations, earnings reporting, and disclosure strategy across her Chief Financial Officer roles and equips her to lead complex capital markets processes. Education: She earned a Bachelor of Arts degree in Political Science and Economics from The Colorado College. Career Highlights: Ms. Munson has served as Chief Financial Officer of Duolingo (Nasdaq: DUOL) from 2026 to the present. She served as Chief Financial Officer of Vimeo, formerly Nasdaq: VMEO, from 2022 to 2025. She served as Chief Financial Officer of Iora Health from 2021 to 2022 and as a Venture Partner at Union Square Ventures from 2019 to 2021. Earlier, she served as Chief Financial Officer of XO Group Inc., formerly NYSE: XOXO, from 2013 to 2019. Key Skills: Her key skills include public company financial leadership, mergers and acquisitions, capital markets and forecasting, audit and financial controls, operational finance, and technology and healthcare industry experience. Other Board Experience: Ms. Munson served on the board of Duolingo (Nasdaq: DUOL) from 2019 to 2026 and on the board of Monster Worldwide, Inc., formerly NYSE: MWW, from 2015 to 2016. Other: She serves as a Board Member of Sweet Briar College and as a Board Member of the Southern Vermont Arts Center.

Ramin Sayar Independent Director Since October 2021 Professional Summary: Ramin Sayar is a public company chief executive officer with experience spanning the full organizational lifecycle and a proven SaaS operating background. As President and Chief Executive Officer of Sumo Logic, a SaaS analytics company, he grew annual revenue from approximately $10 million to more than $300 million in less than a decade, led a successful initial public offering in 2020, and executed a strategic sale to private equity in 2023 at a 57 percent premium for $1.7 billion. He brings firsthand experience operating a technology company across venture, growth-stage, and public company scale. Throughout his career, he has built and scaled enterprise software platforms in dynamic markets, aligning product innovation with commercial execution and go-to-market strategy to drive sustainable revenue growth. At VMware, he led the Cloud Management Business Unit to become the company's fastest-growing division, generating nearly $1 billion in revenue. Technology, Cybersecurity, and Data Governance Expertise: Mr. Sayar has extensive experience developing infrastructure and analytics platforms that manage sensitive enterprise data, which is directly relevant to Phreesia's responsibility to protect patient information and maintain strong internal controls. As a Venture Partner at DFJ Growth, he invests in cloud infrastructure, artificial intelligence, generative AI applications, cybersecurity, and data analytics, providing insight into evolving technology trends that may impact Phreesia's platform and strategy. Capital Markets and Governance Experience: Mr. Sayar brings significant capital markets and governance experience, including leadership of initial public offering preparation, public company reporting, investor engagement, and oversight of major strategic transactions such as Sumo Logic's $1.7 billion sale. His leadership experience at large technology companies enables him to provide operating insight for managing a large-scale, publicly traded software platform. He has served on and chaired board committees across both public and private companies, strengthening board oversight of financial discipline, risk management, strategic planning, and long-term value creation. Education: Mr. Sayar holds a Bachelor of Arts degree in History from the University of California, Santa Barbara, and a Master of Business Administration degree from San Jose State University. Career Highlights: Mr. Sayar has served as a Venture Partner at DFJ Growth from 2024 to the present. He served as President and Chief Executive Officer of Sumo Logic from 2014 to 2023. He previously served as Senior Vice President and General Manager of the Cloud Management Business Unit at VMware, formerly NYSE: VMW, from 2010 to 2014 and as Vice President of Products and Strategy at HP Software, NYSE: HPQ, from 2006 to 2010. Earlier in his career, he held senior leadership roles at TIBCO, Mercury Software, AOL, and Netscape Communications. Key Skills: His key skills include public company chief executive officer leadership, enterprise software and SaaS operations, cloud infrastructure and cybersecurity, artificial intelligence and emerging technologies, capital markets and initial public offering execution, mergers and acquisitions, and board governance and risk oversight. Other Board Experience: Mr. Sayar has served on the boards of XBOW from 2026 to the present, Endor Labs from 2025 to the present, Acceldata from 2024 to the present, Tessian from 2020 to 2023, and JFrog Ltd. (Nasdaq: FROG) from 2014 to 2019.

Mark Smith, M.D. Independent Director since October 2018 Professional Summary: Mark Smith, M.D., is a nationally recognized health policy leader with substantial executive leadership experience. Dr. Smith served as the Founding President and Chief Executive Officer of the California Health Care Foundation for 17 years, building it into a leading independent philanthropy that improved healthcare quality, access, and affordability across California through investments in companies aligned with advancing system-level healthcare improvement. Earlier, he served as Executive Vice President of the Henry J. Kaiser Family Foundation, where he oversaw programs focused on improving outcomes in HIV care, reducing healthcare disparities, and enhancing performance measurement and transparency. Experience and Expertise: Dr. Smith has deep expertise at the intersection of healthcare quality, delivery reform, and innovation. His work has included national initiatives focused on healthcare payment transformation and system redesign, including serving as Co-Chair of the Health Care Payment Learning and Action Network from 2015 to 2019, where he helped shape national strategies around value-based care. Dr. Smith was elected to the National Academy of Medicine in 2011 and chaired the Institute for Healthcare Improvement and the Commonwealth Fund, reflecting decades of leadership in healthcare improvement and policy. Industry and Board Experience: Dr. Smith has extensive board experience across healthcare, life sciences, and philanthropic organizations. He previously served on the board of Teledyne Technologies, a global manufacturer and technology company focused on aerospace, defense, industrial growth markets, and pharmaceuticals. He has also served on numerous nonprofit and foundation boards, including The Institute for Healthcare Improvement and The Commonwealth Fund, bringing experience in governance, oversight, and mission-driven leadership. Education: Dr. Smith earned a Bachelor of Arts degree in Afro-American Studies from Harvard College, a Doctor of Medicine degree from the University of North Carolina at Chapel Hill, and a Master of Business Administration from the Wharton School at the University of Pennsylvania. Key Skills: His key skills include health policy and system reform, technology and healthcare delivery, healthcare quality measurement, patient-reported outcomes, governance, and nonprofit leadership. Other Board Experience: Dr. Smith has served on the boards of Teledyne Technologies from 2005 to the present, Jazz Pharmaceuticals (Nasdaq: JAZZ) from 2020 to the present, The Commonwealth Fund from 2015 to 2024, The Institute for Healthcare Improvement from 2014 to 2023, the National Business Group on Health from 2001 to 2017, and the Archstone Foundation from 1999 to 2019. Other: Dr. Smith serves on the Advisory Board for the RWJF Health Policy Fellows Program and was a 2014 Menschel Senior Policy Fellow at the Harvard School of Public Health.

Lisa Egbuonu-Davis, M.D. Independent Director Since July 2023 She is a senior operating executive with extensive experience across the healthcare ecosystem. As former Vice President of Medical Innovations for Danaher's diagnostics platform, DH Diagnostics, LLC, she provided medical leadership to influence research priorities, partnerships, and investment strategy across Danaher's diagnostic businesses. She also served as Interim Chief Medical Officer for Leica Biosystems and Beckman Coulter, both Danaher subsidiaries, where she provided executive-level medical and operational oversight over new processes for research and development and product innovation. Earlier in her career, Dr. Egbuonu-Davis spent 13 years at Pfizer in senior leadership roles, including Vice President of U.S. Medical Operations, where she led clinical and outcomes research, supported reimbursement strategy and value assessment, and influenced product development and investment decisions across Pfizer's portfolio. She brings deep experience driving patient-centered outcomes and engagement at scale. Her career spans pharmaceuticals, diagnostics, and MedTech innovation, as well as senior advisory roles with Avalere Health and Booz Allen Hamilton. Her broad healthcare experience provides a comprehensive understanding of how providers, payers, and life sciences organizations evaluate healthcare quality, clinical value, and technology adoption. Drawing on behavioral science and patient-reported data, she developed frameworks that translated real-world clinical evidence into economic value for payers and providers, directly connecting patient engagement strategy to reimbursement and market access outcomes. At Sanofi, she developed and led adherence programs and patient services designed to improve measurable outcomes in chronic disease populations. She has significant board and compliance oversight experience. She serves on the boards of Omega Healthcare Investors, a real estate investment trust focused on long-term healthcare facilities, and Avanos Medical, a medical device company focused on orthopedic pain and digestive health. Her committee service spans compensation, nominating and governance, and compliance. Her experience overseeing regulatory and compliance matters at public companies across healthcare services and MedTech sectors equips her to oversee a public healthcare company subject to complex laws, regulations, and industry standards. She holds a Master of Business Administration in Health Care Management from The Wharton School of the University of Pennsylvania. She earned a Doctor of Medicine degree and a Master of Public Health degree in epidemiology from Johns Hopkins University and is board certified in pediatrics. She served as Vice President of Medical Innovations at DH Diagnostics, LLC, a Danaher affiliate, from 2019 to 2023. She served as Interim Chief Medical Officer for Leica Biosystems and Beckman Coulter, Danaher subsidiaries, from 2021 to 2023. She served as Vice President of Global Patient Centered Outcomes and Solutions at Sanofifrom 2015 to 2019. Earlier, she served as Vice President of U.S. Medical Operations at Pfizer from 2003 to 2005 and as Vice President of Global Outcomes Research and Medical Services at Pfizer from 1997 to 2002. She also held senior advisory roles with Avalere Health and Booz Allen Hamilton. Key Skills: Her key skills include clinical and public health expertise, pharmaceutical and diagnostics leadership, patient engagement and outcomes strategy, healthcare commercialization and reimbursement, MedTech and investment strategy, and board governance and compliance oversight. She has served on the board of Omega Healthcare Investors since 2021 and on the board of Avanos Medical since 2023. Other: She has served on the National Advisory Council of the Johns Hopkins University School of Education since 2007 and on the Johns Hopkins Medicine Board of Trustees since 2021.

Independent Director Since July 2020 Professional Summary: Lainie Goldstein is a current public company Chief Financial Officer with deep operational leadership experience. As Chief Financial Officer of Take-Two Interactive Software, she has led finance, accounting, tax, treasury, investor relations, and corporate communications for nearly two decades at a global, publicly traded entertainment and technology company. She has helped guide Take-Two through significant expansion, strengthening financial reporting, disclosure practices, and fiscal discipline as the company scaled and grew profitability to become one of the largest interactive entertainment companies globally. Experience and Expertise: Ms. Goldstein has extensive experience with transformative mergers and acquisitions, integration, and strategic planning. She played an integral role in Take-Two's $12.7 billion acquisition of Zynga in 2022 and other studio acquisitions, including evaluating revenue and cost synergies, communicating transaction details to investors, overseeing integration and transformation efforts, and harmonizing financial forecasting processes. She is known for a collaborative, team-based leadership approach that strengthens operations and strategic execution across complex organizations while maintaining accountability and performance standards. Financial, Risk, and Governance Expertise: During nearly 20 years as a public company Chief Financial Officer, Ms. Goldstein has led initiatives to streamline financial processes, reinforce internal controls, support disciplined capital allocation, and ensure transparent, highly compliant financial reporting. She has implemented cost-reduction programs designed to enhance operating leverage and profitability. Ms. Goldstein qualifies as an audit committee financial expert under Securities and Exchange Commission regulations. Her Certified Public Accountant background and prior audit experience at Grant Thornton LLP strengthen the Board's oversight of accounting integrity and risk management. Her experience overseeing financial and operational risk in a technology-driven environment provides critical insight into matters related to cybersecurity, digital infrastructure, and trust and safety. Education: Ms. Goldstein holds a Bachelor of Science in Business Administration in Accounting from The American University. Career Highlights: Ms. Goldstein has served as Chief Financial Officer of Take-Two Interactive Software, Inc. (Nasdaq: TTWO) since 2007. She previously served as Senior Vice President of Finance at Take-Two Interactive Software from 2003 to 2007 and as Vice President of Finance and Business Development at Nautica Enterprises, Inc. from 1996 to 2003. Earlier in her career, she worked in the Audit and Reorganization Departments at Grant Thornton LLP. Key Skills: Her key skills include public company financial leadership, Securities and Exchange Commission reporting and capital markets, financial controls and audit oversight, mergers and acquisitions and capital raises, operational scale and profitability, cybersecurity and risk management, investor relations and corporate communications, and Certified Public Accountant expertise.

Amy Beth VanDuyn has served as our Senior Vice President of Human Resources since March 2019 and brings more than 20 years of human resources experience to Phreesia, where she is responsible for the design and implementation of all talent strategies, policies and processes across the Company. She previously served as our Vice President of Human Resources from April 2010 until March 2019. Prior to joining Phreesia, Ms. VanDuyn worked in human resource leadership roles across many industries, including hospitality, SaaS and public relations, contributing to the growth and culture of companies at a variety of sizes and stages. Her passion lies in working closely with business leaders to define and implement talent strategies that align with their business goals, and creating environments where people can grow and excel in their careers. Ms. VanDuyn received her B.A. degree in Hospitality Business from Michigan State University.

Yvonne Hui has been appointed to serve as Vice President and Principal Accounting Officer, effective June 20, 2024. Ms. Hui, has served as Vice President, Revenue Recognition and Billing Operations of the Company since March 2022. From August 2021 until March 2022, she served as Google Cloud Controller, Accounting and Reporting at Google LLC. Prior to that from April 2016 until June 2021, she served as Director, Head of Revenue Accounting and Operations at Spotify USA Inc. She holds a Bachelor of Science degree in Accounting from the University of Hull in the United Kingdom and holds an active license as Certified Public Accountant in California.

The Board appointed Jon Kessler to the Board, effective April 6, 2026. Mr. Kessler is an experienced public company CEO and director who will bring valuable expertise to the Phreesia Board. As founder, Chairman and CEO of WageWorks and most recently President and CEO of HealthEquity (NASDAQ:HQY), he has spent the majority of his career leading and scaling healthcare financial services companies, with a deep focus on driving shareholder value creation through technological innovation. Jon Kessler is a seasoned public company executive with more than two decades of leadership experience in healthcare technology and financial services. He most recently served as President and Chief Executive Officer of HealthEquity, where he led the company through its initial public offering and scaled it into a market leader with an enterprise value of approximately $10 billion. Prior to HealthEquity,